Is "somatic" angiotensin I-converting enzyme a mechanosensor?

Diabetes Technology and Therapeutics

Volumn 4, Issue 6, 2002, Pages 841-858

  Moskowitz, David W ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

DIPEPTIDYL CARBOXYPEPTIDASE;

AMINO TERMINAL SEQUENCE; AUTOREGULATION; BLOOD FLOW; CAMBRIAN; PRESSURE; PRIORITY JOURNAL; REVIEW; SENSOR; SHEAR STRESS;

EID: 0036978227     PISSN: 15209156     EISSN: None     Source Type: Journal    
DOI: 10.1089/152091502321118847     Document Type: Review

References (71)

1. Bode W, Gomis-Ruth FX, Stockler W: Astacins, serralysins, snake venom and matrix metalloproteinases exhibit identical zinc-binding environments (HEXXHXXGXXH and Met-turn) and topologies and should be grouped into a common family, the "metzincins." FEBS Lett 1993;331:134-140.
2. Moskowitz DW: Is angiotensin I-converting enzyme a "master" disease gene? Diabetes Technol Ther 2002; 4:683-711.
3. Wagner A: Birth and death of duplicated genes in completely sequenced eukaryotes. Trends Genet 2001;17:237-239.
4. White TK, Wilson JE: Isolation and characterization of the discrete N- and C-terminal halves of rat brain hexokinase: retention of full catalytic activity in the isolated C-terminal half. Arch Biochem Biophys 1989;274:375-393.
5. Wei L, Alhenc-Gelas F, Corvol P, Clauser E: The two homologous domains of human angiotensin I-converting enzyme are both catalytically active. J Biol Chem 1991;266:9002-9008.
6. Bur D, Dale GE, Oefner C: A three-dimensional model of endothelin-converting enzyme (ECE) based on the X-ray structure of neutral endopeptidase 24.11 (NEP). Protein Eng 2001;14:337-341.
7. Coates D, Isaac RE, Cotton J, Siviter R, Williams TA, Shirras A, Corvol P, Dive V: Functional conservation of the active sites of human and Drosophila angiotensin I-converting enzyme. Biochemistry 2000;39: 8963-8969.
8. Laurent V, Stefano G, Salzet M: Presence and biochemical properties of a molluscan invertebrate angiotensin-converting enzyme. Regul Pept 1997;69: 53-61.
9. Turner AJ, Hryszko J, Hooper NM, Dowdall MJ: Purification and characterization of a peptidyl dipeptidase resembling angiotensin converting enzyme from the electric organ of Torpedo marmorata. J Neurochem 1987;48:910-916.
10. Shigei T, Tsuru H, Ishikawa N, Yoshioka K: Absence of endothelium in invertebrate blood vessels: significance of endothelium and sympathetic nerve/medial smooth muscle in the vertebrate vascular system. Jpn J Pharmacol 2001;87:253-260.
11. Jorgensen DD, Ware SK, Redmond JR: Cardiac output and tissue blood flow in the abalone, Haliotis cracherodii (Mollusca, Gastropoda). J Exp Zool 1984; 231:309-324.
12. McMahon BR: Control of cardiovascular function and its evolution in Crustacea. J Exp Biol 2001;204: 923-932.
13. Faury G: Function-structure relationship of elastic arteries in evolution: from microfibrils to elastin and elastic fibres. Pathol Biol 2001;49:310-325.
14. Moskowitz DW, Gillespie KN, Sutera SP, Druce HM, Merli CA, Simon EE: Evidence for acute renal cortical vasoconstriction after uninephrectomy. Ren Fail 1996;18:833-846.
15. Pohl P, Saparov SM, Antonenko YN: The size of the unstirred layer as a function of the solute diffusion coefficient. Biophys J 1998;75:1403-1409.
16. LaBarbera M, Vogel S: The design of fluid transport systems in organisms. Am Sci 1982;70:54-60.
17. LaBarbera M: Principles of design of fluid transport systems in zoology. Science 1990;249:992-1000.
18. Vogel S: Life in Moving Fluids, 2nd edit. Princeton: Princeton University Press, 1994:188.
19. Nollert MU, Diamond SL, McIntire LV: Hydrodynamic shear stress and mass transport modulation of endothelial cell metabolism. Biotechnol Bioeng 1991;38:588-602.
20. Ohno M, Cooke JP, Dzau VJ, Gibbons GH: Fluid shear stress induces endothelial transforming growth factor beta-1 transcription and production. J Clin Invest 1995;95:1363-1369.
21. Haidekker MA, L'Heureux N, Frangos JA: Fluid shear stress increases membrane fluidity in endothelial cells: a study with DCVJ fluorescence. Am J Physiol Heart Circ Physiol 2000;278:H1401-H1406.
22. Vogel S: Life in Moving Fluids, 2nd edit. Princeton: Princeton University Press, 1994:290-330.
23. Holstein-Rathlou NH, Marsh DJ: Renal blood flow regulation and arterial pressure fluctuations: a case study in nonlinear dynamics. Physiol Rev 1994;74: 637-681.
24. Rapacon-Baker M, Zhang F, Pucci ML, Guan H, Nasjletti A: Expression of myogenic constrictor tone in the aorta of hypertensive rats. Am J Physiol Regul Integr Comp Physiol 2001;280:R968-R975.
25. Osol G, Laher I, Kelley M: Myogenic tone is coupled to phospholipase C and G protein activation in small cerebral arteries. Am J Physiol Heart Circ Physiol 1993;265:H415-H420.
26. Wilkes BM: Molecular actions of angiotensin in the kidney. In: Goldfarb S, Ziyadeh FN, Stein JH, eds. Hormones, Autacoids, and the Kidney. New York: Churchill Livingstone, 1991:141-160.
27. Liu X, Fernandez M, Wouters MA, Heyberger S, Husain A: Arg(1098) is critical for the chloride dependence of human angiotensin I-converting enzyme C-domain catalytic activity. J Biol Chem 2001;276: 33518-33525.
28. Sturrock ED, Danilov SM, Riordan JF: Limited proteolysis of human kidney angiotensin-converting enzyme and generation of catalytically active N- and C-terminal domains. Biochem Biophys Res Commun 1997;236:16-19.
29. Thompson KS, Vinson C, Freire E: Thermodynamic characterization of the structural stability of the coiled-coil region of the bZIP transcription factor GCN4. Biochemistry 1993;32:5491-5496.
30. Newsholme EA, Start C: Regulation in Metabolism. London: John Wiley & Sons, 1971:127.
31. Koushanpour E, Kriz W: Renal Physiology, 2nd edit. New York: Springer-Verlag, 1986:353-366.
32. Coyne DW, Morrison AR: Kinins: biotransformation and cellular mechanisms of action. In: Goldfarb S, Ziyadeh FN, Stein JH, eds. Hormones, Autacoids, and the Kidney. New York: Churchill Livingstone, 1991:263-280.
33. Pollman MJ, Naumovski L, Gibbons GH: Vascular cell apoptosis: cell type-specific modulation by transforming growth factor-beta1 in endothelial cells versus smooth muscle cells. Circulation 1999;99:2019-2026.
34. Yamada T, Akishita M, Pollman MJ, Gibbons GH, Dzau VJ, Horiuchi M: Angiotensin II type 2 receptor mediates vascular smooth muscle cell apoptosis and antagonizes angiotensin II type 1 receptor action: an in vitro gene transfer study. Life Sci 1998;63:PL289-PL295.
35. Dunmore-Buyze PJ, Moreau M, Fenster A, Holdsworth DW: In vitro investigation of calcium distribution and tissue thickness in the human thoracic aorta. Physiol Meas 2002;23:555-566.
36. Isoda K, Nishikawa K, Kamezawa Y, Yoshida M, Kusuhara M, Moroi M, Tada N, Ohsuzu F: Osteopontin plays an important role in the development of medial thickening and neointimal formation. Circ Res 2002;91:77-82.
37. Canfield AE, Farrington C, Dziobon MD, Boot-Handford RP, Heagerty AM, Kumar SN, Roberts IS: The involvement of matrix glycoproteins in vascular calcification and fibrosis: an immunohistochemical study. J Pathol 2002;196:228-234.
38. Turitto VT, Goldsmith HL: Rheology, transport, and thrombosis in the circulation. In: Loscalzo J, Creager MA, Dzau VJ, eds. Vascular Medicine, 2nd edit. Boston: Little, Brown and Co., 1996:141-184.
39. Bassingthwaighte JB: Chaos in cardiac signals. Adv Exp Med Biol 1993;346:207-218.
40. Fukuhara M, Geary RL, Diz DI, Gallagher PE, Wilson JA, Glazier SS, Dean RH, Ferrario CM: Angiotensin-converting enzyme expression in human carotid artery atherosclerosis. Hypertension 2000;35:353-359.
41. Diet F, Pratt RE, Berry GJ, Momose N, Gibbons GH, Dzau VJ: Increased accumulation of tissue ACE in human atherosclerotic coronary artery disease. Circulation 1996;94:2756-2767.
42. Strawn WB, Ferrario CM: Mechanisms linking angiotensin II and atherogenesis. Curr Opin Lipidol 2002;13:505-512.
43. Nagai S, Takeuchi M, Morita K, Mikuniya T, Satake N, Mio T, Izumi T: Angiotensin II receptor on BALF macrophages from Japanese patients with active sarcoidosis. Sarcoidosis Vasc Diffuse Lung Dis 1999;16:67-74.
44. Chen H, Li D, Mehta JL: Modulation of matrix metalloproteinase-1, its tissue inhibitor, and nuclear factor-kappa B by losartan in hypercholesterolemic rabbits. J Cardiovasc Pharmacol 2002;39:332-339.
45. Ondetti MA: Structural relationships of angiotensin converting-enzyme inhibitors to pharmacologic activity. Circulation 1988;77:I74-I78.
46. Wei L, Clauser E, Alhenc-Gelas F, Corvol P: The two homologous domains of human angiotensin I-converting enzyme interact differently with competitive inhibitors. J Biol Chem 1992;267:13398-13405.
47. Perich RB, Jackson B, Rogerson F, Mendelsohn FA, Paxton D, Johnston CI: Two binding sites on angiotensin-converting enzyme: evidence from radioligand binding studies. Mol Pharmacol 1992;42:286-293.
48. Moskowitz DW: From pharmacogenomics to improved patient outcomes: angiotensin I-converting enzyme as an example. Diabetes Technol Ther 2002;4: 519-532.
49. Lipowsky HH: Shear stress in the circulation. In: Bevan JA, Kaley G, Rubanyi GM, eds. Flow-Dependent Regulation of Vascular Function. New York: Oxford University Press, 1995:28-45.
50. Cushman DW, Ondetti MA: Design of angiotensin converting enzyme inhibitors. Nat Med 1999;5:1110-1113.
51. Menard J, Patchett AA: Angiotensin-converting enzyme inhibitors. Adv Protein Chem 2001;56:13-75.
52. Colman PM, Jansonius JN, Matthews BW: The structure of thermolysin: an electron density map at 2-3 Å resolution. J Mol Biol 1972;70:701-724.
53. Arndt JW, Hao B, Ramakrishnan V, Cheng T, Chan SI, Chan MK: Crystal structure of a novel carboxypeptidase from the hyperthermophilic archaeon Pyrococcus furiosus. Structure (Camb) 2002;10:215-224.
54. Pauptit RA, Karlsson R, Picot D, Jenkins JA, Niklaus-Reimer AS, Jansonius JN: Crystal structure of neutral protease from Bacillus cereus refined at 3.0 Å resolution and comparison with the homologous but more thermostable enzyme thermolysin. J Mol Biol 1988; 199:525-537.
55. Turner AJ, Hooper NM: The angiotensin-converting enzyme gene family: genomics and pharmacology. Trends Pharmacol Sci 2002;23:177-183.
56. Deddish PA, Marcic B, Jackman HL, Wang HZ, Skidgel RA, Erdos EG: N-domain-specific substrate and C-domain inhibitors of angiotensin-converting enzyme: angiotensin-(1-7) and keto-ACE. Hypertension 1998;31:912-917.
57. Iyer SN, Averill DB, Chappell MC, Yamada K, Allred AJ, Ferrario CM: Contribution of angiotensin-(1-7) to blood pressure regulation in salt-depleted hypertensive rats. Hypertension 2000;36:417-422.
58. Kono T, Taniguchi A, Imura H, Oseko F, Khosla MC: Biological activities of angiotensin II-(1-6)-hexapeptide and angiotensin II-(1-7)-heptapeptide in man. Life Sci 1986;38:1515-1519.
59. Bull HG, Thornberry NA, Cordes MH, Patchett AA, Cordes EH: Inhibition of rabbit lung angiotensin-converting enzyme by N alpha-[(S)-1-carboxy-3-phenylpropyl]L-alanyl-L-proline and N alpha-[(S)-1-carboxy-3-phenylpropyl]L-lysyl-L-proline. J Biol Chem 1985;260:2952-2962.
60. Dive V, Cotton J, Yiotakis A, Michaud A, Vassiliou S, Jiracek J, Vazeux G, Chauvet M-T, Cuniasse P, Corvol P: RXP 407, a phosphinic peptide, is a potent inhibitor of angiotensin I converting enzyme able to differentiate between its two active sites. Proc Natl Acad Sci USA 1999;96:4330-4335.
61. Wei L, Alhenc-Gelas F, Corvol P, Clauser E: The two homologous domains of human angiotensin I-converting enzyme are both catalytically active. J Biol Chem 1991;266:9002-9008.
62. Hwang I, Harper JF, Liang F, Sze H: Calmodulin activation of an endoplasmic reticulum-located calcium pump involves an interaction with the N-terminal autoinhibitory domain. Plant Physiol 2000;122:157-168.
63. Bunning P, Riordan JF: Activation of angiotensin converting enzyme by monovalent anions. Biochemistry 1983;22:110-116.
64. Ehlers MRW, Kirsch RE: Catalysis of angiotensin I hydrolysis by human angiotensin-converting enzyme: effect of chloride and pH. Biochemistry 1988;27: 5538-5544.
65. Shapiro R, Riordan JF: Critical lysine residue at the chloride binding site of angiotensin converting enzyme. Biochemistry 1983;22:5315-5321.
66. Johnston CI, Fabris B, Yamada H, Mendelsohn FA, Cubela R, Sivell D, Jackson B: Comparative studies of tissue inhibition by angiotensin converting enzyme inhibitors. J Hypertens Suppl 1989;7:S11-S16.
67. Soubrier F, Alhenc-Gelas F, Hubert C, Allegrini J, John M, Tregear G, Corvol P: Two putative active centers in human angiotensin I-converting enzyme revealed by molecular cloning. Proc Natl Acad Sci USA 1988; 85:9386-9390.
68. 3H] RU 44 403: role of chloride. Biochem Biophys Res Commun 1989;163:718-725.
69. Fogo AB: Mechanisms in nephrosclerosis and hypertension - beyond hemodynamics. J Nephrol 2001; 14(Suppl 4):S63-S69.
70. Oppong SY, Hooper NM: Characterization of a secretase activity which releases angiotensin-converting enzyme from the membrane. Biochem J 1993;292: 597-603.
71. Parvathy S, Hussain I, Karran EH, Turner AJ, Hooper NM: Alzheimer's amyloid precursor protein alphasecretase is inhibited by hydroxamic acid-based zinc metalloprotease inhibitors: similarities to the angiotensin converting enzyme secretase. Biochemistry 1998;37:1680-1685.